Vir Biotechnology, Inc. · NASDAQ:VIR

Robert Nelsen reported a 7.30% stake in Vir Biotechnology, Inc. (Schedule 13D/A)

Event Nov 4, 2026 · Filed Nov 6, 2026

Robert Nelsen reported a 7.30% stake in Vir Biotechnology, Inc., 12,508,029 shares, with active intent on Nov 4, 2026. Filed Nov 6, 2026 (Schedule 13D/A).

Stake
7.30%
Shares
12,508,029
Intent
Active
What changed
Stake changed
Filed together
8 holders

The filing in full

HolderStakeShares
ARCH Venture Fund IX, L.P.6.90%11,897,988
ARCH Venture Fund IX Overage, L.P.6.90%11,897,988
ARCH Venture Partners IX, L.P.6.90%11,897,988
ARCH Venture Partners IX Overage, L.P.6.90%11,897,988
ARCH Venture Partners IX, LLC6.90%11,897,988
Robert Nelsen7.30%12,508,029
Keith Crandell7.10%12,170,952
Clinton Bybee7.00%11,989,718

Source

Download original · View original at SEC

Related